dr. winter discusses the zuma-7 trial in dlbcl
Published 6 years ago • 460 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
6:45
anticipation of zuma-7 results
-
1:15
primary overall survival analysis of the zuma-7 trial
-
2:08
dr. winter discusses copanlisib in follicular lymphoma
-
1:08
dr. locke on the zuma-6 trial of axi-cel with atezolizumab for dlbcl
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
4:59
zuma-7: axi-cel is superior to standard of care across common prognostic subgroups in r/r lbcl
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
1:15
dr. welslau on the benefits of biosimilars in dlbcl
-
1:14
dr. hamlin on the significance of the zuma-i trial
-
3:24
jason westin, md, on the phase iii zuma-7 primary os analysis
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
-
1:09
dr. neelapu discusses efficacy of axi-cel in large b-cell lymphoma
-
1:25
dr. nowakowski on the rationale for reevaluating enzastaurin in dlbcl
-
2:12
car-t therapy in second-line for nhl: zuma-7, transform & belinda
-
4:26
axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large b-cell lymphoma
-
2:07
dr. hou on polatuzumab vedotin in dlbcl
-
1:35
dr. dogan on updated who classifications in dlbcl